Correspondence
Cannabis-based products for medicinal use
A letter to clinicians from the Chief Medical Officer and NHS England following the rescheduling of legislation to allow the medicinal use of cannabis-based products.
Documents
Details
The letter sets out expectations of what this regulatory change will mean in practice for clinicians working in the NHS and in private practice in England.
Published 2 November 2018